GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 62 filers reported holding GALENA BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,643,000 | -17.6% | 13,266 | +10.7% | 0.00% | – |
| Q2 2016 | $5,635,000 | -87.9% | 11,989 | -62.2% | 0.00% | – |
| Q4 2015 | $46,666,000 | -17.2% | 31,746 | -11.0% | 0.00% | – |
| Q3 2015 | $56,346,000 | +146.4% | 35,662 | +165.1% | 0.00% | – |
| Q2 2015 | $22,872,000 | +504.8% | 13,454 | +394.5% | 0.00% | – |
| Q1 2015 | $3,782,000 | -97.9% | 2,721 | -96.9% | 0.00% | – |
| Q3 2014 | $179,302,000 | +9.0% | 87,041 | +61.9% | 0.00% | – |
| Q2 2014 | $164,540,000 | +20701.5% | 53,772 | +16547.7% | 0.00% | – |
| Q1 2014 | $791,000 | -88.9% | 323 | -77.5% | 0.00% | – |
| Q4 2013 | $7,113,000 | -82.3% | 1,434 | -91.9% | 0.00% | – |
| Q3 2013 | $40,258,000 | -47.6% | 17,657 | -49.0% | 0.00% | – |
| Q2 2013 | $76,843,000 | – | 34,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
| Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
| Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
| Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |